C-reactive protein and Neutrophil-Lymphocyte Ratio as predictors of clinical severity of COVID-19

Authors

  • Stefan Pandilov University Clinic for Eye Diseases; Ss Cyril and Methodius University in Skopje Faculty of Medicine, Republic of North Macedonia
  • Suzana Klenkoski University Clinic for Eye Diseases; Ss Cyril and Methodius University in Skopje Faculty of Medicine, Republic of North Macedonia
  • Elena Jovanovska Janeva University Clinic of Pulmonology and Allergy; Ss Cyril and Methodius University in Skopje, Faculty of Medicine, Republic of North Macedonia
  • Gazmend Mehmeti University Clinic for Eye Diseases; Ss Cyril and Methodius University in Skopje Faculty of Medicine, Republic of North Macedonia
  • Dragan Mijakoski Institute of Occupational Health, WHO CC, GA2LEN CC, Skopje; Ss Cyril and Methodius University in Skopje, Faculty of Medicine, Republic of North Macedonia
  • Sasho Stoleski Institute of Occupational Health, WHO CC, GA2LEN CC, Skopje; Ss Cyril and Methodius University in Skopje, Faculty of Medicine, Republic of North Macedonia
  • Hristian Duma University Clinic for Eye Diseases; Ss Cyril and Methodius University in Skopje Faculty of Medicine, Republic of North Macedonia
  • Dejan Dokic University Clinic of Pulmonology and Allergy; Ss Cyril and Methodius University in Skopje, Faculty of Medicine, Republic of North Macedonia

DOI:

https://doi.org/10.3889/aph.2021.6006

Keywords:

COVID-19, CRP, NLR, neutrophils, lymphocytes, clinical severity

Abstract

COVID-19 is an infectious disease that can manifest quite differently. In this study we examined the relationship between the value of serum CRP(C-reactive protein) andneutrophil-lymphocyte ratio (NLR) as predictor factors for the development of a severe clinical manifestation in COVID19 patients. Materials and methods: We followed 95 COVID-19 positive patients who were hospitalized at the University Clinic for Eye Diseases - COVID Center. We analyzed the initial laboratory parameters of white blood cells and CRP on admission of the patients and the results of laboratory analyses performed before they left the Clinic, or the last parameters before the lethal outcome in those patients who died. Several models of logistic regression were tested to analyze the predictive value of these markers of inflammation for lethal outcome in patients hospitalized for COVID-19. Results: Bivariate analysis demonstrated that the length of hospital stay was significantly shorter in patients with lethal outcome (p=0.001). The NLR was significantly higher in patients with lethal outcome at both times (p=0.005; and p=0.017). Leukocyte’s count (p=0.046, and p<0.001) and CRP (p=0.013,and p=0.005) were also significantly higher in patients with lethal outcome at both times. The increase on the NLR scale both at hospitalization and at discharge (or the last analysis before death) leads to increase in the odds of lethal outcome (T1:40.4% increased odds; T2:36% increased odds). Conclusion: CRP and NLR are laboratory parameters that can predict the severity of the clinical manifestation in patients with COVID-19.

Downloads

Download data is not yet available.

References

Wang W, Lin XD, Guo WP, Zhou RH, Wang MRet al. Discovery, diversity and evolution of novel coronaviruses sampled from rodents in China. Virology 2015 Jan 1;474:19-27. doi: 10.1016/j.virol.2014.10.017

Elezkurtaj S, Greuel S, Ihlow J, Michaelis EG, Bischoff P, et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Sci Rep 2021 Feb 19;11(1):4263. doi: 10.1038/s41598-021-82862-5

Tian W, Jiang W, Yao J, Nicholson CJ, Li RH et al. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. J Med Virol 2020 Oct;92(10):1875-1883. doi: 10.1002/jmv.26050

Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta analysis. J Med Virol 2020; 92(10):1733-1734

Hurlimann J, Thorbecke GJ, Hochwald GM. The liver as the site of C-reactive protein formation. J Exp Med 1966;123(2):365-78. doi: 10.1084/jem.123.2.365.

Young B, Gleeson M, Cripps AW. C-reactive protein: A critical review. Pathology. 1991;23(2):118-124. doi:10.3109/00313029109060809

Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805-1812. doi:10.1172/JCI200318921

Li YP, Mold C, Du Clos TW. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes. J Immunol 1994; 152(6):2995-3005.

Mold C, Baca R, Du Clos TW. Serum amyloid P component and C-reactive protein opsonize apoptotic cells for phagocytosis through Fcgamma receptors. J Autoimmun 2002; 19(3):147-54. doi: 10.1006/jaut.2002.0615.

Forget P, Khalifa C, Defour JP, Latinne D, Van Pel MC, et al. What is the normal value of the neutrophil-to-lymphocyte ratio?. BMC Res Notes 2017;10(1):12. doi:10.1186/s13104-016-2335-5

Kang MH, Go SI, Song HN et al. The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer. Br J Cancer 2014;111(3):452-460. Doi: 10.1038/bjc.2014.317.

Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja Pet al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014;106(6):dju124. doi: 10.1093/jnci/dju124

Ayça B, Akın F, Celik O, Sahin I, Yildiz SS et al. Neutrophil to Lymphocyte Ratio is related to stent thrombosis and high mortality in patients with acute myocardial infarction. Angiology 2015; 66(6):545-52. doi: 10.1177/0003319714542997

Paliogiannis P, Fois AG, Sotgia S, Mangoni AA, Zinellu Eet al. Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives. Eur Respir Rev 2018;27(147):170113. doi: 10.1183/16000617.0113-2017

Fu J, Kong J, Wang W, Wu M, Yao L et al. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thromb Res 2020;192:3-8. doi: 10.1016/j.thromres.2020.05.006

Han Q, Wen X, Wang L, Han X, Shen Y et al. Role of hematological parameters in the diagnosis of influenza virus infection in patients with respiratory tract infection symptoms. J Clin Lab Anal 2020; 34(5):e23191. doi: 10.1002/jcla.23191

Liu YP, Li GM, He J, Liu Y, Li M et al. Combined use of the neutrophil-to-lymphocyte ratio and CRP to predict 7-day disease severity in 84 hospitalized patients with COVID-19 pneumonia: a retrospective cohort study. Ann Transl Med 2020;8(10):635. doi: 10.21037/atm-20-2372

Ghahramani S, Tabrizi R, Lankarani KB, Kashani SMA, Rezaei Set al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res 2020;25(1):30. doi: 10.1186/s40001-020-00432-3

Bao J, Li C, Zhang K, Kang H, Chen W et al. Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19. Clin Chim Acta 2020; 509:180-194. doi: 10.1016/j.cca.2020.06.009

Sun S, Cai X, Wang H, He G, Lin Yet al. Abnormalities of peripheral blood system in patients with COVID-19 in Wenzhou, China. Clin Chim Acta 2020; 507:174-180. doi: 10.1016/j.cca.2020.04.024

Qin C, Zhou L, Hu Z, Zhang S, Yang S et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 2020; 71(15):762-768. doi: 10.1093/cid/ciaa248

Kong M, Zhang H, Cao X, Mao X, Lu Z. Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19. Epidemiol Infect 2020;148:e139. doi: 10.1017/S0950268820001557

Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol 2020;84:106504. doi: 10.1016/j.intimp.2020.106504

Liu X, Zhang R, He G. Hematological findings in coronavirus disease 2019: indications of progression of disease. Ann Hematol 2020; 99(7):1421-1428. doi: 10.1007/s00277-020-04103-5

Huguet E, Maccallini G, Pardini P, Hidalgo M, Obregon Set al. Reference values for Neutrophil to Lymphocyte Ratio (NLR), a biomarker of cardiovascular risk, according to age and sex in a Latin American Population. Curr Probl Cardiol 2021; 46(3):100422. doi: 10.1016/j.cpcardiol.2019.04.002

Russell CD, Parajuli A, Gale HJ, Bulteel NS, Schuetz Pet al. The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and meta-analysis. J Infect 2019;78(5):339-348. doi: 10.1016/j.jinf.2019.02.006

Huang C, Wang Y, Li X, Ren L, Zhao J et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5

Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis 2020;71(15):769-777. doi: 10.1093/cid/ciaa272

Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YBet al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020; 75(7):1730-1741. doi: 10.1111/all.14238

Gao Y, Li T, Han M, Li X, Wu D et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol 2020; 92(7):791-796. doi: 10.1002/jmv.25770

Li K, Wu J, Wu F, Guo D, Chen L et al. The clinical and chest ct features associated with severe and critical COVID-19 pneumonia. Invest Radiol 2020 Jun;55(6):327-331.

Wang C, Deng R, Gou L, Fu Z, Zhang Xet al. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters. Ann Transl Med 2020; 8(9):593. doi: 10.21037/atm-20-3391

Shang W, Dong J, Ren Y, Tian M, Li Wat al. The value of clinical parameters in predicting the severity of COVID-19. J Med Virol 2020; 92(10):2188-2192. doi: 10.1002/jmv.26031

Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020; 84:106504. doi: 10.1016/j.intimp.2020.106504

Liu Y, Du X, Chen J, Jin Y, Peng L et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect 2020; 81(1):e6-e12. doi: 10.1016/j.jinf.2020.04.002

Yan X, Li F, Wang X, Yan J, Zhu F et al. Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: A retrospective cross-sectional study. J Med Virol 2020;92(11):2573-2581. doi: 10.1002/jmv.26061

Tatum D, Taghavi S, Houghton A, Stover J, Toraih E et al. Neutrophil-to-Lymphocyte Ratio and outcomes in Louisiana COVID-19 patients. Shock 2020; 54(5):652-658. doi: 10.1097/SHK.0000000000001585

Liang W, Liang H, Ou L, Chen B, Chen A et al. China Medical Treatment Expert Group for COVID-19. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern Med 2020;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033

Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr 2020; 87(4):281-286. doi: 10.1007/s12098-020-03263-6

Mangalmurti N, Hunter CA. Cytokine Storms: Understanding COVID-19. Immunity 2020; 53(1):19-25. doi: 10.1016/j.immuni.2020.06.017

Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen Wet al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy 2020; 75(7):1564-1581. doi: 10.1111/all.14364

Zhang X, Tan Y, Ling Y, Lu G, Liu F, Yi Z et al. Viral and host factors related to the clinical outcome of COVID-19. Nature 2020;583(7816):437-440. doi: 10.1038/s41586-020-2355-0

Chan AS, Rout A. Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19. J Clin Med Res 2020;12(7):448-453. doi: 10.14740/jocmr4240

Zeng F, Li L, Zeng J, Deng Y, Huang H et al. Can we predict the severity of coronavirus disease 2019 with a routine blood test? Pol Arch Intern Med 2020;130(5):400-406. doi: 10.20452/pamw.15331

Ghahramani S, Tabrizi R, Lankarani KB, Kashani SMA, Rezaei Set al. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis. Eur J Med Res 2020;25(1):30. doi: 10.1186/s40001-020-00432-3

Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. J Med Virol 2020;92(10):1733-1734. doi: 10.1002/jmv.25819

Zhao Q, Meng M, Kumar R, Wu Y, Huang Jet al. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. Int J Infect Dis 2020;96:131-135. doi: 10.1016/j.ijid.2020.04.086

Luo X, Zhou W, Yan X, Guo T, Wang Bet al. Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019. Clin Infect Dis 2020;71(16):2174-2179. doi: 10.1093/cid/ciaa641

Chen W, Zheng KI, Liu S, Yan Z, Xu C et al. Plasma CRP level is positively associated with the severity of COVID-19. Ann Clin Microbiol Antimicrob 2020;19(1):18. doi: 10.1186/s12941-020-00362-2

Wang G, Wu C, Zhang Q, Wu F, Yu B et al. C-Reactive Protein level may predict the risk of COVID-19 aggravation. Open Forum Infect Dis 2020;7(5):ofaa153. doi: 10.1093/ofid/ofaa153

Tan C, Huang Y, Shi F, Tan K, Ma Q et al. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J Med Virol 2020;92(7):856-862. doi: 10.1002/jmv.25871

Published

2021-11-20

How to Cite

1.
Pandilov S, Klenkoski S, Jovanovska Janeva E, Mehmeti G, Mijakoski D, Stoleski S, et al. C-reactive protein and Neutrophil-Lymphocyte Ratio as predictors of clinical severity of COVID-19. Arch Pub Health [Internet]. 2021 Nov. 20 [cited 2026 Nov. 21];13(2):130-43. Available from: https://journals.mk/index.php/aph/article/view/6006

Most read articles by the same author(s)